Sitemap - 2014 - Mendelspod
Cancer 2014: The Year in Review with Anna Barker
Faces of Leadership in Diagnostics: Surbhi Sarna
Historic Consensus Reached on Biospecimen Standards: Carolyn Compton, NBDA
Setting Better Expectations for Genomic Medicine: Geoff Ginsburg, Duke University
Test Driving Genomic Medicine: Thomas Quertermous, Stanford
The Silicon Valley Fantasy Trip: Sci-fi Author Kim Stanley Robinson Talks Life Science
Faces of Leadership in Diagnostics: Mara Aspinall
The Daunting Task of Managing Biospecimens at the World's Largest CRO: Diane Farhi, Quintiles
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
Biosampling Basics with Scott Jewell, Van Andel Institute
Faces of Leadership in Diagnostics: Bonnie Anderson, Veracyte
Biotech’s Gentleman Lawyer: Alan Mendelson
The Open Secret about the HER2 Assay with Jim Vaught
What a Physicist Can Tell Us about Cancer
'Moving Target Science:' Jonathan Brody on Pancreatic Cancer
The Progress of Clinical Genomics in Sweden with Ulf Gyllensten
Proteins Are Where It's At: Chip Petricoin, George Mason University
After a Decade on the Sidelines, Gene Myers Back into Sequencing, Excited about Long Reads
The Story of Aubrey de Grey and How the Study of Aging Became Mainstream
#ScienceHack with Connor Dickie, Synbiota
What Translational Gap? Michael Pishvaian on Advances in Tumor Profiling
A Dangerous Book? Science Historian Nathaniel Comfort Discusses “A Troublesome Inheritance”
Eric Schadt on Long Read Sequencing and Clinical Genomics
Major Sequencing Projects Should Be Done with Long Reads, Says Dan Geraghty
Test Driving Illumina's X Ten with Shawn Baker, AllSeq